Tania Armstrong-Whitworth
Stock Analyst at Canaccord Genuity
(3.82)
# 1,972
Out of 5,000 analysts
142
Total ratings
44.4%
Success rate
6.5%
Average return
Main Sectors:
Stocks Rated by Tania Armstrong-Whitworth
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TSXV: NURS Hydreight Technologies Inc. | Reiterated: Buy | $6.75 | $3.10 | +117.74% | 1 | Sep 2, 2026 | |
| TSXV: DMGI DMG Blockchain Solutions Inc. | Downgraded: Hold | $0.40 → $0.55 | $0.56 | -1.79% | 5 | Aug 27, 2026 | |
| TSX: JWEL Jamieson Wellness Inc. | Downgraded: Hold | $43.50 → $45.75 | $45.43 | +0.70% | 17 | Aug 10, 2026 | |
| TSX: APTX Apotex Health Corp. | Initiated Coverage: Buy | $42.00 | $33.65 | +24.81% | 1 | Jul 13, 2026 | |
| TSX: MSCL Satellos Bioscience Inc. | Initiated Coverage: Buy | $1.25 → $19.00 | $12.01 | +58.20% | 5 | May 21, 2026 | |
| TSX: HLS HLS Therapeutics Inc. | Initiated Coverage: Hold | $4.00 → $5.00 | $3.95 | +26.58% | 20 | May 19, 2026 | |
| TSX: GUD Knight Therapeutics Inc. | Initiated Coverage: Buy | $7.50 → $9.50 | $10.09 | -5.85% | 23 | May 8, 2026 | |
| TSX: EXE Extendicare Inc. | Reiterated: Buy | $13.00 → $22.50 | $31.90 | -29.47% | 2 | Dec 4, 2025 | |
| TSXV: BTCT Bitcoin Treasury Corporation | Reiterated: Buy | $13.50 → $12.25 | $4.06 | +201.72% | 3 | Nov 14, 2025 | |
| TSX: EPRX Eupraxia Pharmaceuticals Inc. | Reiterated: Buy | $9.00 | $11.45 | n/a | 5 | Sep 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $13.00 → $14.00 | $14.27 | n/a | 4 | Aug 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $18.00 → $19.50 | $18.13 | n/a | 4 | Nov 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $4.25 → $3.50 | $3.16 | n/a | 8 | Aug 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $3.00 → $2.65 | $5.07 | n/a | 18 | Jul 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $22 → $18 | $37.65 | n/a | 12 | Nov 21, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Buy | $3.50 → $3.00 | $1.25 | n/a | 14 | Jun 28, 2022 |
Hydreight Technologies Inc.
Sep 2, 2026
Reiterated: Buy
Price Target: $6.75
Current: $3.10
Upside: +117.74%
DMG Blockchain Solutions Inc.
Aug 27, 2026
Downgraded: Hold
Price Target: $0.40 → $0.55
Current: $0.56
Upside: -1.79%
Jamieson Wellness Inc.
Aug 10, 2026
Downgraded: Hold
Price Target: $43.50 → $45.75
Current: $45.43
Upside: +0.70%
Apotex Health Corp.
Jul 13, 2026
Initiated Coverage: Buy
Price Target: $42.00
Current: $33.65
Upside: +24.81%
Satellos Bioscience Inc.
May 21, 2026
Initiated Coverage: Buy
Price Target: $1.25 → $19.00
Current: $12.01
Upside: +58.20%
HLS Therapeutics Inc.
May 19, 2026
Initiated Coverage: Hold
Price Target: $4.00 → $5.00
Current: $3.95
Upside: +26.58%
Knight Therapeutics Inc.
May 8, 2026
Initiated Coverage: Buy
Price Target: $7.50 → $9.50
Current: $10.09
Upside: -5.85%
Extendicare Inc.
Dec 4, 2025
Reiterated: Buy
Price Target: $13.00 → $22.50
Current: $31.90
Upside: -29.47%
Bitcoin Treasury Corporation
Nov 14, 2025
Reiterated: Buy
Price Target: $13.50 → $12.25
Current: $4.06
Upside: +201.72%
Eupraxia Pharmaceuticals Inc.
Sep 2, 2025
Reiterated: Buy
Price Target: $9.00
Current: $11.45
Upside: n/a
Aug 11, 2025
Reiterated: Hold
Price Target: $13.00 → $14.00
Current: $14.27
Upside: n/a
Nov 5, 2024
Reiterated: Buy
Price Target: $18.00 → $19.50
Current: $18.13
Upside: n/a
Aug 8, 2024
Reiterated: Buy
Price Target: $4.25 → $3.50
Current: $3.16
Upside: n/a
Jul 4, 2024
Reiterated: Buy
Price Target: $3.00 → $2.65
Current: $5.07
Upside: n/a
Nov 21, 2022
Reiterated: Buy
Price Target: $22 → $18
Current: $37.65
Upside: n/a
Jun 28, 2022
Downgraded: Buy
Price Target: $3.50 → $3.00
Current: $1.25
Upside: n/a